Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Felker

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Pediatric Blood & Cancer|March 16, 2022
Living in an online world: Social media experiences of adolescents and young adults with cancerHannah Reuman, Katherine Kerr, Jaime Sidani, et al.
Pediatric Blood & Cancer|August 10, 2024
Fertility preservation in pediatric central nervous system tumors: A report from the Children's Oncology GroupJames Felker, Kari Bjornard, Allison Close, et al.
Cancer Genetics|May 21, 2020
Familial Cerebral Cavernous Malformation Syndrome with Concomitant Fourth Ventricular Ependymoma: True Association or Mere Coincidence?Hanna Algattas, Hussam Abou-Al-Shaar, Michael Mendelson, et al.
Pediatric Blood & Cancer|September 4, 2020
Impact of respiratory viral panel testing on length of stay in pediatric cancer patients admitted with fever and neutropeniaKaitlin Shinn, Martha Wetzel, Nicholas P DeGroote, et al.
Cancer Research|June 16, 2019
Identification of Novel RAS Signaling Therapeutic Vulnerabilities in Diffuse Intrinsic Pontine GliomasRobert F Koncar, Brittany R Dey, Ann-Catherine J Stanton, et al.
Science Translational Medicine|March 19, 2025
The T cell receptor landscape of childhood brain tumorsItay Raphael, Zujian Xiong, Chaim T Sneiderman, et al.
Cell Reports|June 13, 2026
MYCN drives pediatric glioma transformation from neural progenitors and creates distinct therapeutic vulnerabilitiesTaylor A Gatesman, Srinidhi Varadharajan, Brenden J Johnson, et al.
Nature Cancer|April 15, 2022
Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenomeBrian J Golbourn, Matthew E Halbert, Katharine Halligan, et al.
Nature Cancer|June 23, 2022
Author Correction: Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenomeBrian J Golbourn, Matthew E Halbert, Katharine Halligan, et al.
Cell Reports|December 19, 2023
An ERK5-PFKFB3 axis regulates glycolysis and represents a therapeutic vulnerability in pediatric diffuse midline gliomaStephanie M Casillo, Taylor A Gatesman, Akanksha Chilukuri, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Pediatric Blood & Cancer|March 16, 2022
Living in an online world: Social media experiences of adolescents and young adults with cancerHannah Reuman, Katherine Kerr, Jaime Sidani, et al.
Pediatric Blood & Cancer|August 10, 2024
Fertility preservation in pediatric central nervous system tumors: A report from the Children's Oncology GroupJames Felker, Kari Bjornard, Allison Close, et al.
Cancer Genetics|May 21, 2020
Familial Cerebral Cavernous Malformation Syndrome with Concomitant Fourth Ventricular Ependymoma: True Association or Mere Coincidence?Hanna Algattas, Hussam Abou-Al-Shaar, Michael Mendelson, et al.
Pediatric Blood & Cancer|September 4, 2020
Impact of respiratory viral panel testing on length of stay in pediatric cancer patients admitted with fever and neutropeniaKaitlin Shinn, Martha Wetzel, Nicholas P DeGroote, et al.
Cancer Research|June 16, 2019
Identification of Novel RAS Signaling Therapeutic Vulnerabilities in Diffuse Intrinsic Pontine GliomasRobert F Koncar, Brittany R Dey, Ann-Catherine J Stanton, et al.
Science Translational Medicine|March 19, 2025
The T cell receptor landscape of childhood brain tumorsItay Raphael, Zujian Xiong, Chaim T Sneiderman, et al.
Cell Reports|June 13, 2026
MYCN drives pediatric glioma transformation from neural progenitors and creates distinct therapeutic vulnerabilitiesTaylor A Gatesman, Srinidhi Varadharajan, Brenden J Johnson, et al.
Nature Cancer|April 15, 2022
Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenomeBrian J Golbourn, Matthew E Halbert, Katharine Halligan, et al.
Nature Cancer|June 23, 2022
Author Correction: Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenomeBrian J Golbourn, Matthew E Halbert, Katharine Halligan, et al.
Cell Reports|December 19, 2023
An ERK5-PFKFB3 axis regulates glycolysis and represents a therapeutic vulnerability in pediatric diffuse midline gliomaStephanie M Casillo, Taylor A Gatesman, Akanksha Chilukuri, et al.
Pageof 2